Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.497NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
C.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AY.43.5 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AA.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
DL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BA.5.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BF.41.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BF.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BA.2.3.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BE.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
HK.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.98NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-17113.5China
CL.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17104.1China
FU.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17104.1China
C.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-17103.8China
AY.9.2.2 (Delta)SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17094.9Japan
BA.2.3.22SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17094.9Japan
XBC.1.6.3SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17094.9Japan
BF.7.12SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17094.9Japan
HK.3.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-17094.9Japan
FU.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17081.4China
GJ.5.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
XBB.1.44.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
XBB.1.5.104ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
AY.114 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
XBB.1.15ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
LF.4.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
CP.7ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BA.2.56ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BA.5.1.23ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BA.5.2.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BA.5.1.19ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BF.34ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
B.1.70ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
B.1.1.265ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
XBB.1.15.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BQ.1.16ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
BA.2.59ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17078.1Japan
BQ.1.8.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17078.1Japan
GA.2.1.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17078.1Japan
JN.2.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17078.1Japan
HV.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-17071Singapore
GE.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-17071Singapore
B.1.36.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-17071Singapore
BA.2.24SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-17060.7Japan
B.1.633NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-17055.8US
CH.1.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17039.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used